DOI:
10.1055/s-00000004
Aktuelle Neurologie
LinksClose Window
References
Hughes AJ, Bishop S, Kleedorfer B. et al
Subcutaneous apomorphine in Parkinson's disease:
Response to chronic administration for up to five years.
Mov Disord 1993; 8: 165-170
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.